filmov
tv
What is MGUS?
Показать описание
In this week’s #AskDrDurie myeloma expert Dr. Brian G.M. Durie discusses monoclonal gammopathy of undetermined significance (MGUS).
The BOTTOM LINE: Monoclonal gammopathy of undetermined significance (MGUS) is a precursor to myeloma, but the chance of progression is only 1% per year.
_______________
Improving Lives | Finding the Cure
Founded in 1990, the International Myeloma Foundation (IMF) is the first and largest organization focusing specifically on multiple myeloma. The IMF’s reach extends to more than 525,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of lives of myeloma patients while working toward prevention and a cure through our four founding principles: Research, Education, Support, and Advocacy.
Find us online:
Category
Nonprofits & Activism
License
Standard YouTube License
In most cases, captions are autogenerated by YouTube.
The BOTTOM LINE: Monoclonal gammopathy of undetermined significance (MGUS) is a precursor to myeloma, but the chance of progression is only 1% per year.
_______________
Improving Lives | Finding the Cure
Founded in 1990, the International Myeloma Foundation (IMF) is the first and largest organization focusing specifically on multiple myeloma. The IMF’s reach extends to more than 525,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of lives of myeloma patients while working toward prevention and a cure through our four founding principles: Research, Education, Support, and Advocacy.
Find us online:
Category
Nonprofits & Activism
License
Standard YouTube License
In most cases, captions are autogenerated by YouTube.
0:02:10
What is MGUS?
0:02:59
What is MGUS?
0:03:47
what is MGUS? Is it cancer? How many people have MGUS, and how long can I have it?
0:02:01
What is Early MGUS?
0:02:08
An introduction to MGUS (Monoclonal Gammopathy of Unknown Significance)
0:02:01
Redefining MGUS to better predict progression to active disease
0:11:35
What is Monoclonal gammopathy of undetermined significance (MGUS)? | NCLEX-RN | Khan Academy
0:03:33
The Role of Lifestyle on MGUS Progression | Betsy O’Donnell, MD | ASCO 2023
0:41:39
PFS 2024 | Myeloma101(Prevalence, Risk Factors, Precursors) & Understanding Your Labs (CT/ PET S...
0:03:16
Are there medical issues linked to MGUS other than developing multiple myeloma?
0:02:54
Do patients with MGUS need to have a bone marrow test?
0:02:50
How is MGUS monitored? Should I see a specialist or seek treatment?
0:03:13
3 things to remember when diagnosing patients with MGUS
0:02:42
The importance of better identifying individuals with MGUS & the possibility of treating precurs...
0:21:56
Monoclonal Gammopathies: What you need to know
0:03:20
MGUS and neuropathy: current understanding and unmet needs
0:05:25
Monoclonal Gammopathy Of Undetermined Significance (MGUS)
0:01:06
What are the biggest challenges associated with treating MGUS?
0:01:56
Do MGUS patients have a higher risk of fracture than people without MGUS? Why?
0:01:50
Insights into the mechanisms leading to progression from MGUS and SMM to multiple myeloma
0:05:34
How Is MGUS Monitored?
0:03:04
Identifying high-risk patients with SMM & MGUS to prevent progression to active myeloma
0:05:30
Changing perceptions of MGUS progression: explaining the data
0:02:02
How to manage monoclonal gammopathy of undetermined significance (MGUS)
Комментарии